Animal & Veterinary

FDA Provides Information on the Use of Medically Important Antimicrobials in Bees

December 18, 2017

The FDA is announcing the availability of a Question and Answer document about the use of medically important antimicrobials in bees to provide helpful information to beekeepers and veterinarians. The Q&A titled “Using Medically Important Antimicrobials in Bees” responds to some commonly asked questions about the appropriate use of approved Veterinary Feed Directive (VFD) and prescription (Rx) drug products for bees.

In January 2017, the FDA and animal drug sponsors completed the voluntary process of transitioning medically important antimicrobial drugs used in animal feed or water from over-the–counter (OTC) marketing status to VFD or Rx marketing status under FDA’s Guidance for Industry (GFI) #213. This marked an important step forward in national efforts to address the use of medically important antimicrobials and promote antimicrobial stewardship in animals. Certain medically important antimicrobial drugs affected by this process are approved for use in bees. As a result, beekeepers have raised questions about how the changes affect them.

Questions not addressed in the Q&A document may be directed to AskCVM@fda.hhs.gov.

Additional Information

Contact FDA

240-402-7002
240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

7500 Standish Place, HFV-1

Rockville, MD 20855

Page Last Updated: 05/07/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English